Publikationen, an denen er mitarbeitet JOSE SCHNEIDER FONTAN (1)

2023

  1. CD44-targeted nanoparticles for co-delivery of docetaxel and an Akt inhibitor against colorectal cancer

    Biomaterials Advances, Vol. 154